Archive: 23/05/2016
Investigational CDK4/6 inhibitor abemaciclib is active against a range of cancer types
The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast ...
May 23, 2016
Many young adult female cancer survivors need more information and support to preserve their fertility
A new study indicates that many young adult female cancer survivors do not receive adequate information about their fertility as part of their survivorship care after completing treatment, despite having concerns about their ...
May 23, 2016
Dietary experiments in mice point the way to early detection of cancer in humans
Colorectal cancer is the second most common cause of cancer-related deaths in the Western world, mainly because it is usually diagnosed too late. Finding ways to identify those people who are at increased risk of developing ...
May 23, 2016